Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Molycorp Reports Second Quarter 2013 Results


FSC / Press Release

Molycorp Reports Second Quarter 2013 Results

Greenwood Village, CO US, August 08, 2013 /FSC/ - Molycorp, Inc (MCP - New York),

HIGHLIGHTS:

. Total volume amounted to 3,039 metric tons (mt) at an average selling price (ASP) of $45.04 per kilogram for the second quarter of 2013. Net revenues for the quarter were $136.9 million.

. For the quarter, the Company reported a net loss of $0.44 per share. The Company reported a net loss of $0.36 per share for the quarter on an adjusted non-GAAP basis.

. The Mountain Pass facility successfully demonstrated an operating capacity in excess of 15,000 mt per year of rare earth oxide (REO) equivalent, making it one of the largest operating rare earth processing facilities in the world.

. In Molycorp's Magnetic Materials and Alloys segment, volume of Magnequench bonded Neo Powders(tm) powders and other alloys increased 21% from the first quarter, and realized pricing increased 3% to drive revenues to $66.1 million, a 21% increase over the same period.

Greenwood Village, CO (August 8, 2013, 4:01 p.m. Eastern) - Molycorp, Inc. (NYSE: MCP) ("Molycorp" or the "Company") today announced financial and operating results for the second quarter of 2013.

SECOND QUARTER 2013 RESULTS

The Company reported consolidated net revenues of $136.9 million during the second quarter of 2013, a 6% decrease over the first quarter of 2013. The decline in revenues was primarily attributable to lower product volumes and slightly lower ASPs.

During the second quarter, the Company sold 3,039 mt of product at an ASP of $45.04 per kilogram and generated a gross loss of $18.5 million, as compared to volume sales of 3,274 mt and revenues of $146.4 million, resulting in a restated gross loss of $4.5 million during the first quarter of 2013. On August 8, 2013, the Company filed a current report on Form 8-K to announce that it intends to file an amended quarterly report on Form 10-Q/A for the three months ended March 31, 2013.

Molycorp reported a loss attributable to common stockholders of $74.0 million, or $0.44 per share. Adjusted loss per share of $0.36 in the second quarter 2013 eliminates the effect of operational expansion items, out-of-ordinary business expenses, and certain other non-cash items.

The Company reported negative cash flows from operating activities of $74.0 million during the first half of 2013, and had $264.2 million in cash and cash equivalents as of June 30, 2013.

During the six months ended June 30, 2013, Molycorp's capital expenditures were $264.7 million on a cash basis. For the remainder of 2013, the Company estimates that its capital expenditures will total approximately $167.0 million.

The Company's Mountain Pass facility successfully demonstrated an operating capacity in excess of 15,000 mt per year of rare earth oxide (REO) equivalent, making it one of the largest operating rare earth processing facilities in the world.

The Mountain Pass facility's chloralkali plant, which will recycle wastewater and regenerate chemical reagents needed for rare earth separations, remains on track for mechanical completion and commissioning in the second half of 2013. After the chloralkali plant is optimized, Company officials expect to achieve the facility's cash production cost targets.

"We are seeing increasingly bullish signals from customers across several segments for product demand, and increased demand will coincide nicely with increased production capacity at Mountain Pass and declining production costs," said Constantine Karayannopoulos, President and CEO. "As we continue to optimize operations at Mountain Pass, and bring up the chloralkali plant in the second half of 2013, we should be ready to adjust production to meet customer demand and be price competitive with any rare earth producer in the world."

CONFERENCE CALL TODAY AT 4:30 P.M. EASTERN DAYLIGHT TIME

Molycorp will conduct a conference call today to discuss these results at 4:30 p.m. EDT, hosted by Mr. Karayannopoulos, President and Chief Executive Officer, Michael Doolan, Executive Vice President and Chief Financial Officer, and Geoff Bedford, Executive Vice President and Chief Operating Officer. Investors interested in participating in the live call from the U.S. should dial +1 (866) 953-6860 and reference passcode number 93032772. Those calling from outside the U.S. should dial +1 (617) 399-3484 and reference the same passcode as above.

There will also be a simultaneous live audio webcast available on the Investor Relations section of the Company's website at www.molycorp.com/investors. The webcast will be archived on the website. A PowerPoint presentation that will be broadcast live via webcast during the conference call will be made available on the website immediately prior to the call.

NON-GAAP ADJUSTED NET LOSS, EBITDA and ADJUSTED EBITDA

Adjusted net loss is a non-GAAP measure that excludes certain non-cash items and other out-of-ordinary business expense and operational expansion items. EBITDA is also a non-GAAP measure that excludes interest, tax, depreciation and amortization. Adjusted EBITDA consists of EBITDA excluding certain non-cash items and other out-of-ordinary business expense and operational expansion items. The Company's management believes adjusting out these items, including but not limited to purchase accounting adjustments, stock-based compensation, out-of-ordinary expenses/income, asset impairment charges and other miscellaneous charges, is useful to investors because it provides an overall understanding of the Company's historical financial performance and future prospects. Management believes adjusted net loss, EBITDA and adjusted EBITDA are an indication of the Company's base-line performance. Exclusion of these items permits evaluation and comparison of results for the Company's core business operations, and it is on this basis that management internally assesses the Company's performance.

# # #

FOR MORE INFORMATION:

Company Contacts:

Jim Sims, +1 (303) 843-8062 Vice President Corporate Communications Jim.Sims@Molycorp.com

Brian Blackman, +1 (303) 843-8067 Vice President Investor Relations Brian.Blackman@Molycorp.com

FINANCIAL STATEMENTS AND SUPPLEMENTARY TABLES

TABLE 1: BALANCE SHEETS

MOLYCORP, INC. Consolidated Balance Sheets (In thousands, except share and per share amounts)

-***-

June 30, 2013 December 31,

2012

-------------------------------

(Revised)

ASSETS Current assets: Cash and cash equivalents $ 264,162 $ 227,790 Trade accounts receivable, net 51,117 52,430 Inventory 213,733 287,376 Deferred charges 5,107 9,412 Deferred tax assets 9,079 9,789 Income tax receivable 20,296 25,087 Prepaid expenses and other 21,168 21,794

current assets

-------------------------------

Total current assets 584,662 633,678

------------------------------- Non-current assets: Deposits 26,632 26,769 Property, plant and equipment, net 1,713,258 1,544,304 Inventory 24,663 26,096 Intangible assets, net 430,596 450,938 Investments 61,082 64,036 Deferred tax assets - - Goodwill 239,742 239,742 Other non-current assets 6,547 6,972

-------------------------------

Total non-current assets 2,502,520 2,358,857

------------------------------- Total assets $ 3,087,182 $ 2,992,535

------------------------------

LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities:

Current liabilities: Trade accounts payable $ 104,981 $ 241,994 Accrued expenses 45,357 59,013 Income tax payable 10,971 15,267 Deferred tax liabilities 55 - Debt and capital lease obligations 14,638 39,604 Other current liabilities 5,639 3,539

-------------------------------

Total current liabilities 181,641 359,417

------------------------------- Non-current liabilities: Asset retirement obligation 15,161 18,586 Deferred tax liabilities 134,617 160,675 Debt and capital lease obligations 1,348,990 1,188,832 Derivative liability 6,660 7,816 Pension liabilities 3,384 3,292 Other non-current liabilities 2,287 2,659

-------------------------------

Total non-current liabilities 1,511,099 1,381,860

-------------------------------

(Revised)

------------------------------- Total liabilities $ 1,692,740 $ 1,741,277

------------------------------- Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value; 189 139

350,000,000 shares authorized at

June 30, 2013 Preferred stock, $0.001 par value; 2 2

5,000,000 shares authorized at

June 30, 2013 Additional paid-in capital 1,947,983 1,691,429 Accumulated other comprehensive loss (12,065) (9,433) Accumulated deficit (576,237) (466,091)

-------------------------------

Total Molycorp stockholders' equity 1,359,872 1,216,046

Noncontrolling interests 34,570 35,212

-------------------------------

Total stockholders' equity 1,394,442 1,251,258

------------------------------- Total liabilities and stockholders' equity $ 3,087,182 $ 2,992,535

-------------------------------

-****_

TABLE 2: INCOME STATEMENTS

MOLYCORP, INC. Consolidated Statements of Operations and Comprehensive Income (In thousands, except share and per share amounts)

-***-

Three Months Ended June 30, -------------------------------------------------------------------------

2013 2012 ------------------------------------------------------------------------- Revenues $ 136,862 $ 104,577 Costs of sales: Costs excluding depreciation and (136,792) (103,569)

amortization Depreciation and amortization (18,574) (5,081) ------------------------------------------------------------------------- Gross profit (loss) (18,504) (4,073) Operating expenses: Selling, general and administrative (25,807) (23,070) Corporate development (73) (14,925) Depreciation, amortization and accretion (8,293) (2,279) Research and development (6,506) (6,049) Impairment of goodwill and other long- (377) -

lived assets -------------------------------------------------------------------------

Operating loss (59,560) (50,396) ------------------------------------------------------------------------- Other (expense) income: Other income (expense) 1,827 (30,980) Foreign exchange gain (loss), net 1,667 (2,789) Interest expense, net of capitalized interest (14,869) (9,805) -------------------------------------------------------------------------

(11,375) (43,574) -------------------------------------------------------------------------

Loss before income taxes and equity (70,935) (93,970)

earnings

Income tax benefit 3,530 27,303

Equity in results of affiliates (3,284) (257) -------------------------------------------------------------------------

Net loss (70,689) (66,924)

Net income attributable to

non-controlling interest (486) (680) ------------------------------------------------------------------------- Net loss attributable to Molycorp stockholders $(71,175) $ (67,604) ------------------------------------------------------------------------- Net loss $(70,689) $ (66,924) Other comprehensive income: Foreign currency translation adjustments 662 (4,221) -------------------------------------------------------------------------

Comprehensive loss $(70,027) $ (71,145) ------------------------------------------------------------------------- Comprehensive loss attributable to:

Molycorp stockholders (69,541) (70,465)

Noncontrolling interest (486) (680) -------------------------------------------------------------------------

$(70,027) $ (71,145) -------------------------------------------------------------------------

Loss per share of common stock:

Basic $ (0.44 ) $ (0.71) -------------------------------------------------------------------------

Diluted $ (0.44 ) $ (0.71) -------------------------------------------------------------------------

Six Months Ended June 30, -------------------------------------------------------------------------

2013 2012 ------------------------------------------------------------------------- Revenues $ 283,229 $ 189,047 Costs of sales: Costs excluding depreciation and (273,386) (153,641)

amortization Depreciation and amortization (32,883) (8,452) ------------------------------------------------------------------------- Gross profit (loss) (23,040) 26,954 Operating expenses: Selling, general and administrative (52,321) (47,253) Corporate development (188) (18,305) Depreciation, amortization and accretion (16,516) (2,637) Research and development (12,911) (9,699) Impairment of goodwill and other long- (377) -

lived assets -------------------------------------------------------------------------

Operating loss (105,353) (50,940) ------------------------------------------------------------------------- Other (expense) income: Other income (expense) 2,086 (37,558) Foreign exchange gain (loss), net 1,278 (1,185) Interest expense, net of capitalized interest (26,518) (9,720) -------------------------------------------------------------------------

(23,154) (48,463) -------------------------------------------------------------------------

Loss before income taxes and equity (128,507) (99,403)

earnings

Income tax benefit 26,021 29,485

Equity in results of affiliates (6,356) (484) -------------------------------------------------------------------------

Net loss (108,842) (70,402)

Net income attributable to noncontrolling

Interest (1,304) (680) ------------------------------------------------------------------------- Net loss attributable to Molycorp stockholders $(110,146) $ (71,082) ------------------------------------------------------------------------- Net loss $(108,842) $ (70,402) Other comprehensive income: Foreign currency translation adjustments (2,632) (1,691) -------------------------------------------------------------------------

Comprehensive loss $(111,474) $ (72,093) ------------------------------------------------------------------------- Comprehensive loss attributable to:

Molycorp stockholders (110,170) (71,413)

Noncontrolling interest (1,304) (680) -------------------------------------------------------------------------

$(111,474) $ (72,093) -------------------------------------------------------------------------

Loss per share of common stock:

Basic $ (0.72) $ (0.82) -------------------------------------------------------------------------

Diluted $ (0.72) $ (0.82) -------------------------------------------------------------------------

TABLE 3: STATEMENTS OF CASH FLOWS

-***-

MOLYCORP, INC

Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

Six Months Ended June 30, -------------------------------------------------------------------------

2013 2012 -------------------------------------------------------------------------

Cash flows from operating activities: Net loss $ (108,842) $ (70,402) Adjustments to reconcile net loss to net cash from operating activities:

Depreciation, amortization and accretion 49,399 11,089

Deferred income tax benefit (29,496) (12,131)

Inventory write-downs 47,958 26,106

Release of inventory step-up value 3,499 8,361

Stock-based compensation expense 794 1,900

Allowance for doubtful accounts - 2,500

Foreign exchange loss 667 1,214

Equity in results of affiliates 6,356 484

Other operating adjustments (1,513) 33

Net change in operating assets and

liabilities (42,863) (33,535) -------------------------------------------------------------------------

Net cash used in by operating

activities (74,041) (64,381) ------------------------------------------------------------------------- Cash flows from investing activities: Cash paid in connection with acquisition, - (591,011) net of cash acquired Investment in joint ventures (3,423) (14,805) Deposits - (488) Capital expenditures (264,726) (403,932) Other investing activities (224) 2 -------------------------------------------------------------------------

Net cash used in investing

activities (268,373) (1,010,234) ------------------------------------------------------------------------- Cash flows from financing activities: Capital contributions - 390,225 Repayments of debt (27,283) (2,188) Net proceeds from sale of common stock 248,150 - Net proceeds from sale of Senior Notes - 635,373 Issuance of 5.50% Convertible Notes 165,600 - Payments of preferred dividends (5,693) (5,693) Proceeds from debt - 9,745 Dividend paid to noncontrolling interests (1,946) - Other financing activities (360) (2,394) -------------------------------------------------------------------------

Net cash provided by financing

activities 378,468 1,025,068 ------------------------------------------------------------------------- Effect of exchange rate changes

on cash 318 (46) -------------------------------------------------------------------------

Net change in cash and cash

equivalents 36,372 (49,593) Cash and cash equivalents at beginning

of the period 227,790 418,855 ------------------------------------------------------------------------- Cash and cash equivalents at end

of period $ 264,162 $ 369,262 -------------------------------------------------------------------------

-****-

-***-

Three months ended Resources Chemicals and Magnetic June 30, 2013 Oxides Materials

and

Alloys (In Thousands) ------------------------------------------------------------------------- Revenues: External $ 10,922 $ 34,789 $ 66,114 Intersegment 6,665 6,692 - ------------------------------------------------------------------------- Total revenues $ 17,587 $ 41,481 $ 66,114 ------------------------------------------------------------------------- Depreciation, amortization $ (11,629) $ (5,589) $ (7,422) and accretion Operating (loss) income $ (40,404) $ (15,174) $ 10,638 (Loss) income before income $ (39,215) $ (14,019) $ 10,898 axes and equity earnings Total assets at June 30,

2013 $ 1,953,529 $ 605,486 $ 592,499 Capital expenditures (c) $ 55,693 $ 1,138 $ 411

Three months ended Rare Corporate Eliminations June 30, 2013 Metals And (b)

Other

(a) ------------------------------------------------------------------------- Revenues: External $ 25,037 $ - Intersegment - (13,357 ) ------------------------------------------------------------------------- Total revenues $ 25,037 $ (13,357 ) ------------------------------------------------------------------------- Depreciation,

amortization $ (2,170 ) $ (57 ) $ - and accretion Operating (loss) income $ (3,381 ) $ (9,953 ) $ (1,286 ) (Loss) income before

income $ 129 $ (27,442 ) $ (1,286 ) axes and equity earnings Total assets at

June 30, 2013 $ 103,412 $ 912,660 $ (1,080,404 ) Capital expenditures (c) $ 719 $ 93 $ -

Three months ended Total June 30, 2013 Molycorp, Inc. ----------------------------------------------- Revenues: External $ 136,862 Intersegment - ----------------------------------------------- Total revenues $ 136,862 ----------------------------------------------- Depreciation, amortization $ (26,867 ) and accretion Operating (loss) income $ (59,560 ) (Loss) income before income $ (70,935 ) axes and equity earnings Total assets at June 30, 2013 $ 3,087,182 Capital expenditures (c) $ 58,054

Three Months Ended Resources Chemicals Magnetic June 30, 2012 And Materials and

Oxides Alloys ------------------------------------------------------------------------- Revenues: External $ 16,533 $ 39,019 $ 31,532 Intersegment 400 726 - ------------------------------------------------------------------------- Total revenues $ 16,933 $ 39,745 $ 31,532 ------------------------------------------------------------------------- Depreciation, amortization $ (2,594) $ (1,419) $ (1,877) and accretion Operating (loss) income $ (17,158) $ (10,475) $ (3,107) Loss before income taxes $ (17,137) $ (11,970) $ (3,460) Capital expenditures (c) $ 228,787 $ 5,254 $ 832

Three Months Ended Rare Corporate Eliminations June 30, 2012 Metals And (B)

Other(A) ------------------------------------------------------------------------- Revenues: External $ 17,493 $ - Intersegment - (1,126 ) ------------------------------------------------------------------------- Total revenues $ 17,493 $ (1,126 ) ------------------------------------------------------------------------- Depreciation, amortization $ (1,399) $ (29) $ (42 ) and accretion Operating (loss) income $ 478 $ (30,436) $ 10,302 Loss before income taxes $ (1,375) $ (70,330) $ 10,302 Capital expenditures (c) $ - $ - $ -

Three Months Ended Total June 30, 2012 Molycorp, Inc. ----------------------------------------- Revenues: External $ 104,577 Intersegment - ----------------------------------------- Total revenues $ 104,577 ----------------------------------------- Depreciation, amortization $ (7,360) and accretion Operating (loss) income $ (50,396) Loss before income taxes $ (93,970) Capital expenditures (c) $ 234,873

-****-

(a) Corporate loss before income taxes and equity earnings includes business development costs, personnel and related costs, including stock-based compensation expense, accounting and legal fees, occupancy expense, information technology costs and interest expense. Total corporate assets is comprised primarily of cash and cash equivalents and deferred tax assets.

(b) The net elimination in operating results includes costs of sales eliminations of $12,071 and $11,470 for the three months ended June 30, 2013 and 2012, respectively. Costs of sales eliminations consist of intercompany gross profits as well as eliminations of lower of cost or market adjustments related to intercompany inventory. The total assets elimination is comprised primarily of intercompany investments and intercompany accounts receivable and profits in inventory.

(c) On an accrual basis excluding capitalized interest.

TABLE 5: LOSS PER SHARE

-***-

(In thousands, except share and per share amounts)

Three Months Ended June 30,

------------------------------

2013 2012

------------------------------ Net loss attributable to Molycorp stockholders $ (71,175) $ (67,604)

Dividends on Convertible Preferred Stock (2,846) (2,846)

------------------------------ Loss attributable to common stockholders (74,021) (70,450)

------------------------------ Weighted average common shares outstanding - basic 168,075,012 99,175,285

Basic loss per share $ (0.44) $ (0.71)

============================= Weighted average common shares outstanding diluted 168,075,012 99,175,285

Diluted loss per share $ (0.44) $ (0.71)

-****-

TABLE 6: PRODUCT REVENUES, VOLUMES, ASP

-***-

Three Months Ended June 30,

------------------------------- Revenues (in thousands) 2013 2012

------------------------------- Resources (1) $ 17,587 $ 16,933 Chemicals and Oxides (2) 41,481 39,745 Magnetic Materials and Alloys (3) 66,114 31,532 Rare Metals (4) 25,037 17,493 Intersegments eliminations (13,357) (1,126)

------------------------------- Total Net Revenues $ 136,862 $ 104,577

===============================

-------------------------------

Three Months Ended June 30,

------------------------------- Volumes (in metric tons) 2012 2013

------------------------------- Resources 1,049 525 Chemicals and Oxides 1,266 692 Magnetic Materials and Alloys 1,485 579 Rare Metals 92 94 Intersegments eliminations (853) (198)

3,039 1,692

===============================

-------------------------------

Three Months Ended June 30,

------------------------------- ASP per kilogram 2013 2012

------------------------------- Resources $ 16.77 $ 32.25 Chemicals and Oxides $ 32.76 $ 57.47 Magnetic Materials and Alloys $ 44.52 $ 80.18 Rare Metals $ 272.14 $ 187.35

-****-

1. The Resources segment includes the Company's operations at its Molycorp Mountain Pass facility where it conducts rare earth minerals extraction to produce: rare earth concentrates; REO, including lanthanum, cerium, neodymium, praseodymium and yttrium; heavy rare earth concentrate, which includes samarium, europium, gadolinium, terbium, dysprosium, and others; and SorbXTM , a line of proprietary rare earth-based water treatment products, formerly known as XSORBX.

2. The Chemicals and Oxides division includes: production of REO at the Company's operations in Sillamae, Estonia; heavy rare earth oxides other custom engineered materials from the Company's facilities in Jiangyin, Jiangsu Province, China; and production of REO, salts of rare earth elements ("REEs"), zirconium-based engineered materials and mixed rare earth/zirconium oxides from the Company's facilities in Zibo, Shandong Province, China. Rare earth and zirconium applications from products made in this segment include catalytic converters, computers, television display panels, optical lenses, mobile phones, electronic chips, and many others.

3. The Magnetic Materials and Alloys segment includes: the production of Neo Powders(tm) through the Company's wholly-owned manufacturing facilities in Tianjin, China, and Korat, Thailand, under the Molycorp Magnequench brand. This operating segment also includes manufacturing of neodymium and samarium magnet alloys, other specialty alloy products and rare earth metals at the Molycorp Metals and Alloys ("MMA") facility, located in Tolleson, Arizona. Neo Powders(tm) are used in micro motors, precision motors, sensors, and other applications requiring high levels of magnetic strength, flexibility, small size, and reduced weight.

4. The Rare Metals segment produces, reclaims, refines and markets high value niche metals and their compounds that include gallium, indium, rhenium, tantalum, and niobium. Operations in this segment include the following: Quapaw, Oklahoma; Blanding, Utah; Peterborough, Ontario; Napanee, Ontario; Sagard, Germany; Hyeongok Industrial Zone in South Korea; and Sillamae, Estonia. Applications from products made in this segment include wireless technologies, light-emitting diode ("LED"), flat panel display, turbine, solar, catalyst, steel additive, electronics applications, and others.

TABLE 7: NON-GAAP ADJUSTED NET LOSS, EBITDA and ADJUSTED EBITDA RECONCILIATION

(In thousands, except share and per share data)

-***-

------------------------------------------------------------------------- Adjusted Net Loss -------------------------------------------------------------------------

Three Months Ended June 30, -------------------------------------------------------------------------

2013 2012 ------------------------------------------------------------------------- Net loss attributable to Molycorp stockholders (71,175) $ (67,604) Certain non-cash and other items: - Stock-based compensation 1,037 1,075 Inventory write-downs 14,330 19,542 Impact of purchase accounting on cost of inventory sold 1,002 8,361 Out-of-ordinary items: Water removal 4,964 4,532 Molycorp Mountain Pass non-capitalizable costs 540 4,278 Business Expansion items: Due diligence and other transaction costs - 53,756 Other business expansion expenses 254 3,466 Income tax effect of above adjustments (8,966) (27,553) ------------------------------------------------------------------------- Adjusted net (loss) income (58,014) (147) Dividends on Convertible Preferred Stock (2,846) (2,846) ------------------------------------------------------------------------- Adjusted net (loss) income attributed to common stockholders $ (60,860) $ (2,993) ------------------------------------------------------------------------- Weighted average common shares outstanding 168,075,012 99,175,285 ------------------------------------------------------------------------- Adjusted net (loss) earnings per share $ (0.36) $ (0.03) -------------------------------------------------------------------------

-****-

-***-

EBITDA and Adjusted EBITDA Three months ended June 30, 2013 ------------------------------------------------------------------------- Operating loss $ (59,560) Depreciation and amortization included in costs of sales 18,574 Depreciation, amortization and accretion 8,293 ------------------------------------------------------------------------- EBITDA (32,693) ------------------------------------------------------------------------- Stock-based compensation 1,037 Inventory write-downs 14,330 Impact of purchase accounting on cost of inventory sold 1,002 Water removal 4,964 Molycorp Mountain Pass non-capitalizable costs 540 ------------------------------------------------------------------------- Other business expansion expenses 254 ------------------------------------------------------------------------- Adjusted EBITDA $ (10,566)

-****-

ABOUT MOLYCORP

Molycorp is the only advanced material manufacturer in the world that both controls a world-class rare earth resource and can produce high-purity, custom engineered rare earth products to meet increasingly demanding customer specifications. A globally integrated manufacturer, the Company produces a wide variety of specialized products from 13 different rare earths (lights and heavies), five rare metals (gallium, indium, rhenium, tantalum and niobium), and the transition metals yttrium and zirconium. With 27 locations across 11 countries, Molycorp also produces rare earth magnetic materials through its Molycorp Magnequench subsidiary, including neodymium-iron-boron ("NdFeB") magnet powders, used to manufacture bonded NdFeB permanent rare earth magnets. Through its joint venture with Daido Steel and the Mitsubishi Corporation, Molycorp manufactures next-generation, sintered NdFeB permanent rare earth magnets. Through its Molycorp Advanced Water Technologies subsidiary, the Company markets and sells its proprietary, cerium-based advanced water purification technology called SorbX(tm) for use in municipal and industrial wastewater treatment, recreational water, and pool and spa water treatment markets. For more information please visit http://www.molycorp.com.

SAFE HARBOR STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements that represent Molycorp's beliefs, projections and predictions about future events or Molycorp's future performance. Forward-looking statements can be identified by terminology such as "may," "will," "would," "could," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other similar expressions or phrases. These forward-looking statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause Molycorp's actual results, performance or achievements or industry results to differ materially from any future results, performance or achievement described in or implied by such statements.

Factors that may cause actual results to differ materially from expected results described in forward-looking statements include, but are not limited to: the potential need to secure additional capital to implement Molycorp's business plans, and Molycorp's ability to successfully secure any such capital; Molycorp's ability to complete its planned capital projects, such as its modernization and expansion efforts, including the achievement of an initial annual production rate of 19,050 metric tons at the Mountain Pass rare earth mine and processing facility, which we refer to as the Molycorp Mountain Pass facility, and reach full planned production rates for REO and other planned downstream products, in each case within the projected time frame; the success of Molycorp's cost mitigation efforts in connection with the modernization and expansion efforts at the Molycorp Mountain Pass facility, which, if unsuccessful, might cause its costs to exceed budget; the final costs of Molycorp's planned capital projects, which may differ from estimated costs; Molycorp's ability to successfully integrate Neo Material Technologies, Inc. (now Molycorp Canada), with its operations; Molycorp's ability to achieve fully the strategic and financial objectives related to the acquisition of Molycorp Canada, including the acquisition's impact on Molycorp's financial condition and results of operations; unexpected costs or liabilities that may arise from the acquisition, ownership or operation of Molycorp Canada; risks and uncertainties associated with intangible assets, including any future goodwill impairment charges; market conditions, including prices and demand for Molycorp's products; Molycorp's ability to control its working capital needs; foreign exchange rate fluctuations; the development and commercialization of new products; unexpected actions of domestic and foreign governments; various events which could disrupt operations, including natural events and other risks; uncertainties associated with Molycorp's reserve estimates and non-reserve deposit information, including estimated mine life and annual production; uncertainties related to feasibility studies that provide estimates of expected or anticipated costs, expenditures and economic returns, REO prices, production costs and other expenses for operations, which are subject to fluctuation; uncertainties regarding global supply and demand for rare earths materials; uncertainties regarding the results of Molycorp's exploratory drilling programs; Molycorp's ability to enter into additional definitive agreements with its customers and its ability to maintain customer relationships; Molycorp's sintered neodymium-iron-boron rare earth magnet joint venture's ability to successfully manufacture magnets within its expected timeframe; Molycorp's ability to successfully integrate other acquired businesses; Molycorp's ability to maintain appropriate relations with unions and employees; Molycorp's ability to successfully implement its vertical integration strategy; environmental laws, regulations and permits affecting Molycorp's business, directly and indirectly, including, among others, those relating to mine reclamation and restoration, climate change, emissions to the air and water and human exposure to hazardous substances used, released or disposed of by Molycorp; and uncertainties associated with unanticipated geological conditions related to mining; and the outcome of the stockholder class action litigation, derivative litigation and the SEC investigation, including any actions taken by government agencies in connection therewith.

For more information regarding these and other risks and uncertainties that Molycorp may face, see the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended December 31, 2012 and of the Company's Quarterly Reports on Form 10-Q. Any forward-looking statement contained in this release or the Annual Report on Form 10-K or the Quarterly Reports on Form 10-Q reflects Molycorp's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Molycorp's operations, operating results, growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak only as to the date when made. Molycorp assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, except as otherwise required by applicable law.

To view this press release as a PDF, please click on the following link: http://www.usetdas.com/pr/molycorp08082013.pdf

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Provider ID: 00022035 -0- Aug/08/2013 20:07 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement